Physician profile
Nikitha Reddy
NPI 1730671389
$9,474.28
in general payments reported to CMS, 2019-2025
7 companies · $2,454 in 2025
The $2,454 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $49.28 · 2024: $6,971 · 2025: $2,454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,640 · Consulting Fee: $1,950 · Food and Beverage: $1,616 · Travel and Lodging: $219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,639.96 |
| Consulting Fee | $1,950.00 |
| Food and Beverage | $1,615.56 |
| Travel and Lodging | $219.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $6,218.80 | 2024 | Omni Surgical System |
| Lensar, INC. | $2,194.03 | 2025 | Lensar Laser System |
| Abbvie INC. | $381.32 | 2024-2025 | |
| Bausch & Lomb Americas INC. | $309.52 | 2024-2025 | Vyzulta, Miebo, Xiidra |
| Alcon Vision LLC | $248.93 | 2024-2025 | Clareon, Simbrinza |
| Sun Pharmaceutical Industries INC. | $50.55 | 2025 | Cequa |
| Harrow Eye, LLC | $21.85 | 2024 | Vevye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikitha Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.